Carlos Vargas
Mayo Clinic
CancerInternal medicineRadiologyUrologySurgeryOncologyBeam (structure)ProstateLung cancerBrachytherapyProton therapyProstate cancerRectumToxicityNuclear medicineCollaborative groupRadiation therapyBreast cancerProtonMedicine
194Publications
25H-index
2,560Citations
Publications 173
Newest
#1Jacob S. Parzen (Oakland University)H-Index: 1
#2Michael D. ChuongH-Index: 16
Last. Mark V. MishraH-Index: 14
view all 13 authors...
Abstract null null Purpose null Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spare adjacent critical organs, improving toxicity profiles and potentially improving clinical outcomes. null null null Methods and Materials null We evaluated the REG001-09 registry for patients undergoing proton radiation therapy for esophageal cancer. Demographic, clinicopathologic, toxicity, and dosimetry information were c...
Source
#1Gabriella F. Bulman (Mayo Clinic)
#2R.S. Bhangoo (Mayo Clinic)H-Index: 3
Last. Steven E. Schild (Mayo Clinic)H-Index: 81
view all 11 authors...
Source
#1Aylen Vanessa Ospina (University of Los Andes)H-Index: 1
#2Ricardo Brugés (Pontifical Xavierian University)H-Index: 1
Last. Néstor LlinásH-Index: 1
view all 35 authors...
INTRODUCTION The ACHOCC-19 study was performed to characterize COVID-19 infection in our oncological population. METHODOLOGY Analytical cohort study of patients with cancer and COVID-19 infection in Colombia. From April 1 to October 31, 2020. Demographic and clinical variables related to cancer and COVID-19 infection were collected. The primary outcome was 30-day mortality from all causes. The association between the outcome and the prognostic variables was analyzed using logistic regression mod...
Source
PURPOSE As patients with mediastinal lymphoma are typically young with curable disease, advanced radiation techniques such as proton therapy are often considered to minimize subacute and late toxicity. However, it is unclear which mediastinal lymphoma patients are treated with proton therapy. Within a prospective, multi-institutional proton registry, we characterized mediastinal lymphoma patients treated with proton therapy and assessed concordance with consensus recommendations published in 201...
Source
#1Robert H. PressH-Index: 13
Last. Ii Cbs
view all 12 authors...
Source
#1Jacob B. Hammond (Mayo Clinic)H-Index: 2
#2Heidi E. Kosiorek (Mayo Clinic)H-Index: 18
Last. Barbara A. Pockaj (Mayo Clinic)H-Index: 57
view all 10 authors...
Abstract Background Capsular contracture causes pain, poor cosmesis, and reoperations. This study analyzes its incidence and risk factors in a more modern treatment era. Methods Patients undergoing mastectomy with implant reconstruction from 2010 to 18 were reviewed. Univariate and multivariate analysis evaluated rates and risk factors for capsular contracture. Results Among 451 patients, the majority underwent nipple-sparing mastectomy (262, 58.1%) with one-stage reconstruction (283, 62.7%) uti...
1 CitationsSource
#1Curtis Bryant (UF: University of Florida)H-Index: 9
#2Randal H. Henderson (UF: University of Florida)H-Index: 20
Last. Nancy P. Mendenhall (UF: University of Florida)H-Index: 66
view all 18 authors...
Source
#1J. Anderson (Mayo Clinic)H-Index: 2
#2Jacob B. Hammond (Mayo Clinic)H-Index: 2
Last. Carlos Vargas (Mayo Clinic)H-Index: 25
view all 17 authors...
Study conducted to determine frequency and timing of unplanned breast implant removal after mastectomy, reconstruction, and postmastectomy radiation (PMRT). From 2010-2017, 52 patients underwent mastectomy, reconstruction, and PMRT. With median follow-up of 3.1 years, 23 patients (44%) experienced implant removal. Implant removal occurred in 9 (17%) patients before starting PMRT and 14 (27%) patients after starting PMRT. Implant removal rates were similar for hypofractionated PMRT compared with ...
Source
#1Yunze Yang (Mayo Clinic)
#1Yunze Yang (Mayo Clinic)H-Index: 12
Last. Wei Liu (Mayo Clinic)H-Index: 22
view all 15 authors...
Abstract Purpose We proposed a novel tool of dose-linear-energy-transfer (LET) volume histogram (DLVH) and performed an exploratory study to investigate rectal bleeding in prostate cancer treated by intensity-modulated proton therapy (IMPT). Methods DLVH was constructed with dose and LET as two axes, while the normalized volume of the structure was contoured in the dose-LET plane as iso-volume lines. We defined DLVH index, DL v % ( d , l ), i.e., v % of the structure have a dose of ≥ d Gy and an...
Source
#1Neha Vapiwala (UPenn: University of Pennsylvania)H-Index: 26
#2J. Karen Wong (Fox Chase Cancer Center)H-Index: 1
Last. Eric M. Horwitz (Fox Chase Cancer Center)H-Index: 72
view all 15 authors...
Abstract Purpose Data comparing moderately hypofractionated intensity-modulated radiation therapy (IMRT) and proton beam therapy (PBT) are lacking. We aim to compare late toxicity profiles of patients with early stage prostate cancer treated with moderately hypofractionated PBT and IMRT. Materials and Methods This multi-institutional analysis included patients with low- or intermediate-risk biopsy-proven prostate adenocarcinoma from 7 tertiary referral centers treated from 1998 to 2018. All pati...
2 CitationsSource